½ÃÀ庸°í¼­
»óǰÄÚµå
1300855

¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : À¯Çüº°, »ýüÀç·áº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Upper Extremity Implants Market Size study & Forecast, by Type, by Biomaterial, by End Use and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è »óÁö ÀÓÇöõÆ® ½ÃÀåÀº 2022³â ¾à 17¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 6.8% ÀÌ»óÀÇ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

»óÁö ÀÓÇöõÆ®´Â ¾î±ú, ÆÈ²ÞÄ¡, ¼Õ¸ñ, ¼ÕÀ» Æ÷ÇÔÇÑ »óÁöÀÇ Ä¡·á¿Í ȸº¹À» À§ÇØ Æ¯º°È÷ ¼³°èµÇ°í »ç¿ëµÇ´Â ÀÇ·á±â±â¿Í ÀÓÇöõÆ®¸¦ ¸»ÇÕ´Ï´Ù. »óÁö ¼Õ»óÀ̳ª Áõ»óÀÌ Àִ ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇÔÀÔ´Ï´Ù. »óÁö ÀÓÇöõÆ® ½ÃÀåÀº »óÁö ¼ö¼ú °Ç¼ö Áõ°¡¿Í ½ºÆ÷Ã÷ °ü·Ã ºÎ»ó ¹ß»ý °Ç¼ö Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ ÀÓÇöõÆ®´Â °üÀý ġȯ¼ú, °ñÀý °íÁ¤¼ú, ÈûÁÙ º¹¿ø¼ú, Àδë Àç°Ç¼ú µî ´Ù¾çÇÑ Á¤Çü¿Ü°ú ¼ö¼ú¿¡ »ç¿ëµÇ¾î »óÁö ºÎ»ó ¹× Áõ»óÀ» °¡Áø ȯÀÚÀÇ À̵¿¼ºÀ» ȸº¹ÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½Ãŵ´Ï´Ù. ¹Ì±¹ Á¤Çü¿Ü°ú ÇÐȸ¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â ¸Å³â 53,000°Ç ÀÌ»óÀÇ ¾î±ú °üÀý ġȯ¼úÀÌ ½ÃÇàµÇ¾î ¾î±ú °ü·Ã Áõ»ó°ú ºÎ»ó¿¡ ´ëÇÑ ¿Ü°úÀû °³ÀÔÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. À¯¿£ÀÌ 2022³â ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, ¼¼°è 65¼¼ ÀÌ»ó ³ëÀÎ Àα¸´Â 2050³â±îÁö 2¹è ÀÌ»ó Áõ°¡ÇÏ¿© 2020³â 7¾ï 2,700¸¸ ¸í¿¡¼­ 2050³â 15¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌó·³ °í·ÉÈ­ Àα¸ Áõ°¡´Â Á¤Çü¿Ü°úÀû ¹®Á¦ Áõ°¡¿Í Áø´Ü, Ä¡·á, ¼ö¼úÀ» À§ÇÑ º´¿ø ¹æ¹® Áõ°¡¸¦ °¡Á®¿Ã °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ±Ù°ñ°Ý°è Áúȯ Áõ°¡¿Í ¸ÂÃãÇü ÀÓÇöõÆ® ½ÃÀå °³Ã´Àº ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¿¬±¸°³¹ß¿¡ µû¸¥ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÀϹÝÀûÀÎ ¾î±ú ºÎ»ó Áõ°¡¿Í ±âÁ¸ ÀÇ·á ½Ã¼³ÀÇ °í·ÉÈ­·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Á¤Çü¿Ü°ú ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í °í·ÉÈ­ Àα¸ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î °£Áֵ˴ϴÙ.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2020-2030³â
    • »óÁö ÀÓÇöõÆ® ½ÃÀå : Áö¿ªº°, 2020-2030³â
    • »óÁö ÀÓÇöõÆ® ½ÃÀå : À¯Çüº°, 2020-2030³â
    • »óÁö ÀÓÇöõÆ® ½ÃÀå : »ýü Àç·áº°, 2020-2030³â
    • »óÁö ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, 2020-2030³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ÀüÁ¦Á¶°Ç

Á¦2Àå ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ ¹ßÀü
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå ¿ªÇÐ

  • »óÁö ÀÓÇöõÆ® ½ÃÀå¿¡ ´ëÇÑ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : À¯Çüº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : À¯Çüº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • »óÁö ÀÓÇöõÆ® ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¾î±ú
    • ÆÈ²ÞÄ¡
    • ¼Õ ¹× ¼Õ¸ñ

Á¦6Àå ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : »ýü Àç·áº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : »ýü Àç·áº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : »ýü Àç·áº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • »óÁö ÀÓÇöõÆ® ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ±Ý¼Ó ¹ÙÀÌ¿À¼ÒÀç
    • ¼¼¶ó¹Í »ýü Àç·á
    • °íºÐÀÚ »ýü Àç·á
    • õ¿¬ ¹ÙÀÌ¿À¼ÒÀç

Á¦7Àå ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • »óÁö ÀÓÇöõÆ® ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø
    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • Ŭ¸®´Ð

Á¦8Àå ¼¼°èÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • »óÁö ÀÓÇöõÆ® ½ÃÀå, ½ÃÀå ÇöȲ, Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
      • À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • »ýü Àç·áº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ »óÁö ÀÓÇöõÆ® ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Stryker corporation
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • DePuy synthes
    • Zimmer Biomet holdings
    • Smith & Nephew Plc.
    • Medtronic Plc.
    • Aesculap AG
    • BioTek Instruments
    • Conmed corporation
    • Arthrex, Inc.
    • Ossur hf.

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç ÀüÁ¦Á¶°Ç
LSH 23.07.31

Global Upper extremity implants Market is valued approximately at USD 1.7 billion in 2022 and is anticipated to grow with a growth rate of more than 6.8% over the forecast period 2023-2030. The Upper extremity implants refers to the medical devices and implants specifically designed and used for the treatment and restoration of the upper limbs, including the shoulder, elbow, wrist, and hand. In order to improve the quality of life for patients with upper extremity injuries or conditions. The Upper extremity implants Market is driven by factors such as the rising number of upper limb surgeries and rising incidences of sports-associated injuries.

These implants are used in various orthopedic procedures, such as joint replacement, fracture fixation, tendon repair, and ligament reconstruction, to restore mobility and improve the quality of life for patients with upper limb injuries or conditions. According to the American Academy of Orthopaedic Surgeons, more than 53,000 shoulder replacement surgeries are conducted annually in the United States, addressing shoulder-related conditions and injuries with surgical interventions. According to the data published by the UN in 2022, the number of people aged 65 years or above is expected to more than double globally by 2050, rising from 727 million in 2020 to 1.5 billion in 2050. Thus, the increasing aging population is also expected to increase in number of orthopedic problems and hospital visits for diagnosis, treatment, and surgeries.In addition to the increasing cases musculoskeletal disorders and development of customized implants may create lucrative opportunities for the market growth. However, the high cost associated with research & development may hinder the market growth.

The key regions considered for the Global Upper extremity implants Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising common shoulder injury and aging established healthcare facility. Asia Pacific considered as the fastest growing region during forecasted period due to rising demand in orthopedics surgery and increasing aging population.

Major market players included in this report are:

  • Stryker corporation
  • DePuy synthes
  • Zimmer Biomet Holdings
  • Smith & Nephew Plc.
  • Medtronic Plc.
  • Aesculap AG
  • BioTek Instruments
  • Conmed corporation
  • Arthrex, Inc.
  • Ossur hf.

Recent Developments in the Market:

  • On Oct 2022, Integrum, a medical device company, announced the successful patent approval by the US Patent and Trade Organization for its groundbreaking OPRA Implant System. This innovative system involves the direct attachment of prostheses to the bone, offering a novel approach in bone-anchored prostheses technology. The OPRA system is versatile and applicable for both upper and lower limb amputations, providing improved functionality and quality of life for amputees.

Global Upper Extremity Implants Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Biomaterial, End Use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Shoulder
  • Elbow
  • Hand & Wrist

By Biomaterial:

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Natural Biomaterials

By End Use:

  • Hospitals,
  • ASCs
  • Clinics

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Upper Extremity Implants Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Upper Extremity Implants Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Upper Extremity Implants Market, by Biomaterial, 2020-2030 (USD Billion)
    • 1.2.4. Upper Extremity Implants Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Upper Extremity Implants Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Upper Extremity Implants Market Dynamics

  • 3.1. Upper Extremity Implants Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising number of upper limb surgeries
      • 3.1.1.2. Rising incidence of sports-associated injuries
    • 3.1.2. Market Challenges
      • 3.1.2.1. Infection risk and implant failure
      • 3.1.2.2. Surgical complexity
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing cases musculoskeletal disorders
      • 3.1.3.2. Development of customized implants

Chapter 4. Global Upper Extremity Implants Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Upper Extremity Implants Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Upper Extremity Implants Market by Type, Performance - Potential Analysis
  • 5.3. Global Upper Extremity Implants Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Upper Extremity Implants Market, Sub Segment Analysis
    • 5.4.1. Shoulders
    • 5.4.2. Elbow
    • 5.4.3. Hand & Wrist

Chapter 6. Global Upper Extremity Implants Market, by Biomaterial

  • 6.1. Market Snapshot
  • 6.2. Global Upper Extremity Implants Market by Biomaterial, Performance - Potential Analysis
  • 6.3. Global Upper Extremity Implants Market Estimates & Forecasts by Biomaterial 2020-2030 (USD Billion)
  • 6.4. Upper Extremity Implants Market, Sub Segment Analysis
    • 6.4.1. Metallic Biomaterials
    • 6.4.2. Ceramic Biomaterials
    • 6.4.3. Polymeric Biomaterials
    • 6.4.4. Natural Biomaterial

Chapter 7. Global Upper Extremity Implants Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Upper Extremity Implants Market by End Use, Performance - Potential Analysis
  • 7.3. Global Upper Extremity Implants Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
  • 7.4. Upper Extremity Implants Market, Sub Segment Analysis
    • 7.4.1. Hospitals,
    • 7.4.2. ASCs
    • 7.4.3. Clinics

Chapter 8. Global Upper Extremity Implants Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Upper Extremity Implants Market, Regional Market Snapshot
  • 8.4. North America Upper Extremity Implants Market
    • 8.4.1. U.S. Upper Extremity Implants Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Biomaterial breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Upper Extremity Implants Market
  • 8.5. Europe Upper Extremity Implants Market Snapshot
    • 8.5.1. U.K. Upper Extremity Implants Market
    • 8.5.2. Germany Upper Extremity Implants Market
    • 8.5.3. France Upper Extremity Implants Market
    • 8.5.4. Spain Upper Extremity Implants Market
    • 8.5.5. Italy Upper Extremity Implants Market
    • 8.5.6. Rest of Europe Upper Extremity Implants Market
  • 8.6. Asia-Pacific Upper Extremity Implants Market Snapshot
    • 8.6.1. China Upper Extremity Implants Market
    • 8.6.2. India Upper Extremity Implants Market
    • 8.6.3. Japan Upper Extremity Implants Market
    • 8.6.4. Australia Upper Extremity Implants Market
    • 8.6.5. South Korea Upper Extremity Implants Market
    • 8.6.6. Rest of Asia Pacific Upper Extremity Implants Market
  • 8.7. Latin America Upper Extremity Implants Market Snapshot
    • 8.7.1. Brazil Upper Extremity Implants Market
    • 8.7.2. Mexico Upper Extremity Implants Market
  • 8.8. Middle East & Africa Upper Extremity Implants Market
    • 8.8.1. Saudi Arabia Upper Extremity Implants Market
    • 8.8.2. South Africa Upper Extremity Implants Market
    • 8.8.3. Rest of Middle East & Africa Upper Extremity Implants Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Stryker corporation
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. DePuy synthes
    • 9.3.3. Zimmer Biomet holdings
    • 9.3.4. Smith & Nephew Plc.
    • 9.3.5. Medtronic Plc.
    • 9.3.6. Aesculap AG
    • 9.3.7. BioTek Instruments
    • 9.3.8. Conmed corporation
    • 9.3.9. Arthrex, Inc.
    • 9.3.10. Ossur hf.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦